This study is being conducted to evaluate the safety and effect of starting daily use of low dose (100 mg) aspirin in pregnant women with sickle cell disease, who are being followed in two county hospitals in Angola, in the first trimester versus the second trimester of the gestational period.
Phase:
PHASE1
Details
Lead Sponsor:
Instituto Nacional de Investigacao em Saude, Angola
Collaborators:
CLINCOORD PRESTAÇÃO DE SEVIÇOS, LDA ANGOLA ClinCoord Research Center at Luanda Medical Center CLINCOORD SERVICES, INC. Escola Superior de Tecnologia da Saúde de Lisboa FUNDAÇAO CALOUSTE GULBENKIAN FUNDACIÓN BANCARIA CAIXA D'ESTALVIS I PENSIONS DE BARCELONA